Neurizon Therapeutics (ASX: NUZ) has reported positive results from an independent study into the effects of neuroprotective ...

NUZ-001 has shown it promotes healthy and viable brain tissues, potentially demonstrating its use to treat Alzheimer’s and ...

Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...

Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.

NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, Tylah Tully gives the ...

Watch the video to see the initiatives Neurizon is taking. This video was developed in collaboration with Neurizon ...

Telix Pharmaceuticals (ASX:TLX) has won marketing approval for its prostate cancer imaging agent in Brazil, marking the company’s first foray into the South American market. The Brazilian Health ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Telix Pharmaceuticals’ Brazilian win marks its first foray into the South American market Orthocell ...

In a report released today, Iain Wilkie from Morgans maintained a Buy rating on Pharmaust Limited (ECQ0 – Research Report), with a price target of A$0.42. The company’s shares closed last ...